首页 > 最新文献

Surgery最新文献

英文 中文
Discussion. 讨论。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-15 DOI: 10.1016/j.surg.2024.08.053
{"title":"Discussion.","authors":"","doi":"10.1016/j.surg.2024.08.053","DOIUrl":"https://doi.org/10.1016/j.surg.2024.08.053","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of surgical management in mitigating fragility fracture risk among individuals with primary hyperparathyroidism. 手术治疗在降低原发性甲状旁腺功能亢进症患者脆性骨折风险方面的效果。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-15 DOI: 10.1016/j.surg.2024.08.052
Bahar Golbon, Rogeh Habashi, Jonas Shellenberger, Rebecca Griffiths, Lisa Avery, Minna Woo, Daniel Pincus, Antoine Eskander, Jesse D Pasternak

Background: Primary hyperparathyroidism predominately affects women who are postmenopausal and causes complications, including fragility fractures. Its treatment is parathyroidectomy, which is associated with low complication and >95% cure rates. Considering fractures are associated with premature death, we aimed to determine whether the surgical management of individuals with biochemical diagnosis of primary hyperparathyroidism was associated with a reduction in fracture risk.

Methods: In this population-based cohort study, we used administrative health databases to identify adults ≥18 year old who were biochemically diagnosed with primary hyperparathyroidism between 2007 and 2016 in Ontario. Patients were included if their calcium was ≥2.6 mmol/L (≥10.42 mg/dL) with a concurrent parathyroid hormone of ≥2.2 pmol/L (≥20.75 pg/mL). We followed patients and compared the incidence of fractures between those with and without parathyroidectomy. To control for potential confounding, we used inverse probability of treatment weighting to estimate the average treatment effect in the treated. Fine-Gray competing risk regression models were used to determine the association between surgery and time to fracture.

Results: In a cohort of 28,059 with a biochemical diagnosis of primary hyperparathyroidism, the mean age (standard deviation) was 65 years (14.2 years), and 75% (n = 21,139) were female. Only 12.6% (n = 3,523) underwent parathyroidectomy. Weighted fracture cumulative incidence at 12 years postdiagnosis was 10.17% (n = 182) in surgical patients and 14.04% (n = 2,004) in nonsurgical patients. Parathyroidectomy prevented 1 fracture for every 26 surgeries performed (weighted risk difference, 3.87%, 95% confidence interval, 0.96%-6.62%) and reduced the hazard of fracture by 22% (weighted hazard ratio, 0.78; 95% confidence interval, 0.64-0.95).

Conclusion: In a large, publicly funded health system, parathyroidectomy significantly reduced the short- and long-term risk of fragility fractures in patients with primary hyperparathyroidism.

背景:原发性甲状旁腺功能亢进症主要影响绝经后的妇女,并导致包括脆性骨折在内的并发症。其治疗方法是甲状旁腺切除术,并发症少,治愈率>95%。考虑到骨折与过早死亡有关,我们旨在确定对生化诊断为原发性甲状旁腺功能亢进的患者进行手术治疗是否与降低骨折风险有关:在这项基于人群的队列研究中,我们使用行政健康数据库来识别安大略省在 2007 年至 2016 年间被生化诊断为原发性甲状旁腺功能亢进症的年龄≥18 岁的成年人。如果患者的血钙≥2.6 mmol/L(≥10.42 mg/dL),同时甲状旁腺激素≥2.2 pmol/L(≥20.75 pg/mL),则将其纳入研究。我们对患者进行了随访,并比较了进行和未进行甲状旁腺切除术的患者的骨折发生率。为了控制潜在的混杂因素,我们采用了反概率治疗加权法来估算治疗者的平均治疗效果。精细格雷竞争风险回归模型用于确定手术与骨折发生时间之间的关系:在生化诊断为原发性甲状旁腺功能亢进的28059名患者中,平均年龄(标准差)为65岁(14.2岁),75%(n=21139)为女性。只有12.6%(3523人)接受了甲状旁腺切除术。手术患者在确诊后12年的加权骨折累积发生率为10.17%(n = 182),非手术患者为14.04%(n = 2,004)。每进行26例手术,甲状旁腺切除术可预防1例骨折(加权风险差异为3.87%,95%置信区间为0.96%-6.62%),骨折风险降低22%(加权风险比为0.78;95%置信区间为0.64-0.95):结论:在大型公立医疗系统中,甲状旁腺切除术可显著降低原发性甲状旁腺功能亢进症患者短期和长期脆性骨折的风险。
{"title":"The effect of surgical management in mitigating fragility fracture risk among individuals with primary hyperparathyroidism.","authors":"Bahar Golbon, Rogeh Habashi, Jonas Shellenberger, Rebecca Griffiths, Lisa Avery, Minna Woo, Daniel Pincus, Antoine Eskander, Jesse D Pasternak","doi":"10.1016/j.surg.2024.08.052","DOIUrl":"https://doi.org/10.1016/j.surg.2024.08.052","url":null,"abstract":"<p><strong>Background: </strong>Primary hyperparathyroidism predominately affects women who are postmenopausal and causes complications, including fragility fractures. Its treatment is parathyroidectomy, which is associated with low complication and >95% cure rates. Considering fractures are associated with premature death, we aimed to determine whether the surgical management of individuals with biochemical diagnosis of primary hyperparathyroidism was associated with a reduction in fracture risk.</p><p><strong>Methods: </strong>In this population-based cohort study, we used administrative health databases to identify adults ≥18 year old who were biochemically diagnosed with primary hyperparathyroidism between 2007 and 2016 in Ontario. Patients were included if their calcium was ≥2.6 mmol/L (≥10.42 mg/dL) with a concurrent parathyroid hormone of ≥2.2 pmol/L (≥20.75 pg/mL). We followed patients and compared the incidence of fractures between those with and without parathyroidectomy. To control for potential confounding, we used inverse probability of treatment weighting to estimate the average treatment effect in the treated. Fine-Gray competing risk regression models were used to determine the association between surgery and time to fracture.</p><p><strong>Results: </strong>In a cohort of 28,059 with a biochemical diagnosis of primary hyperparathyroidism, the mean age (standard deviation) was 65 years (14.2 years), and 75% (n = 21,139) were female. Only 12.6% (n = 3,523) underwent parathyroidectomy. Weighted fracture cumulative incidence at 12 years postdiagnosis was 10.17% (n = 182) in surgical patients and 14.04% (n = 2,004) in nonsurgical patients. Parathyroidectomy prevented 1 fracture for every 26 surgeries performed (weighted risk difference, 3.87%, 95% confidence interval, 0.96%-6.62%) and reduced the hazard of fracture by 22% (weighted hazard ratio, 0.78; 95% confidence interval, 0.64-0.95).</p><p><strong>Conclusion: </strong>In a large, publicly funded health system, parathyroidectomy significantly reduced the short- and long-term risk of fragility fractures in patients with primary hyperparathyroidism.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A large single-center analysis of postoperative hemorrhage in more than 43,000 thyroid operations: The relevance of intraoperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender (in-)congruence. 对43000多例甲状腺手术术后出血的大型单中心分析:术中收缩压、外科医生和外科医生与患者性别(不)一致的相关性。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-15 DOI: 10.1016/j.surg.2024.10.003
Anna Plötzl, Anna Wicher, Malwina Jarosz, Christian Passler, Stefan Haunold, Johannes Ott, Michael Hermann

Background: To date, there is no reliable measure for the prevention of postoperative hemorrhage after thyroid surgery. An increase in the postoperative hemorrhage rate at our institution in 2021 prompted us to look for possible causes with a special focus on perioperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender congruence.

Methods: We drew on our prospectively managed database to review 43,360 consecutive thyroid surgeries. In addition to a risk factor analysis, a subanalysis of perioperative systolic blood pressure values was performed in 26 patients with postoperative hemorrhage and 26 controls, on the basis of the hypothesis that a targeted pharmacologic increase in systolic blood pressure could reveal covert sources of bleeding.

Results: Postoperative hemorrhage developed in 707 of 43,360 cases (1.6%). Risk factors included older age (odds ratio, 1.017), male gender (odds ratio, 1.629), Graves disease (odds ratio, 1.515), and recurrent benign thyroid disease (odds ratio, 1.693). The individual surgeon significantly influenced the rate of postoperative hemorrhage (odds ratio, up to 2.817). Surgeon-to-patient gender (in)congruence did not affect the rate of postoperative hemorrhage. The subanalysis of perioperative blood pressure revealed mostly arterial bleeding sources (17/26 [65.4%]) and significantly lower intraoperative yet greater postoperative systolic blood pressure values (100 mm Hg vs median 120 mm Hg; P = .009; and 150 mm Hg vs 130 mm Hg; P = .005; respectively) in patients who later developed postoperative hemorrhage.

Conclusion: Although our data suggest that increasing intraoperative systolic blood pressure before wound closure may help to detect covert bleeding sources and therefore prevent postoperative hemorrhage, future studies are necessary to substantiate this finding. We recommend close collaboration with anesthesiologists as well as counteracting postoperative blood pressure increases. The individual surgeon was a major factor influencing the rate of postoperative hemorrhage. However, there were no differences between female and male surgeons operating on female or male patients.

背景:迄今为止,还没有预防甲状腺手术术后出血的可靠措施。2021 年,我院的术后出血率有所上升,这促使我们寻找可能的原因,并特别关注围手术期收缩压、外科医生个人以及外科医生与患者之间的性别一致性:我们利用前瞻性管理数据库回顾了 43360 例连续甲状腺手术。除了风险因素分析外,我们还对 26 名术后出血患者和 26 名对照组患者的围手术期收缩压值进行了子分析,其假设是有针对性的药物升高收缩压可以揭示隐蔽的出血源:结果:43360 例患者中有 707 例(1.6%)出现术后出血。风险因素包括年龄较大(几率比1.017)、男性(几率比1.629)、巴塞杜氏病(几率比1.515)和复发性甲状腺良性疾病(几率比1.693)。外科医生对术后出血率的影响很大(几率比最高为 2.817)。外科医生与患者的性别(不)一致并不影响术后出血率。对围术期血压进行的子分析显示,术后出血的患者大多来自动脉出血(17/26 [65.4%]),术中收缩压值显著较低,但术后收缩压值却显著升高(分别为 100 mm Hg vs 中位 120 mm Hg;P = .009;150 mm Hg vs 130 mm Hg;P = .005):尽管我们的数据表明,在伤口闭合前增加术中收缩压可能有助于发现隐蔽的出血源,从而预防术后出血,但未来的研究仍有必要证实这一发现。我们建议与麻醉师密切合作,并对抗术后血压升高。外科医生个人是影响术后出血率的主要因素。然而,为女性或男性患者进行手术的外科医生之间并无差异。
{"title":"A large single-center analysis of postoperative hemorrhage in more than 43,000 thyroid operations: The relevance of intraoperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender (in-)congruence.","authors":"Anna Plötzl, Anna Wicher, Malwina Jarosz, Christian Passler, Stefan Haunold, Johannes Ott, Michael Hermann","doi":"10.1016/j.surg.2024.10.003","DOIUrl":"https://doi.org/10.1016/j.surg.2024.10.003","url":null,"abstract":"<p><strong>Background: </strong>To date, there is no reliable measure for the prevention of postoperative hemorrhage after thyroid surgery. An increase in the postoperative hemorrhage rate at our institution in 2021 prompted us to look for possible causes with a special focus on perioperative systolic blood pressure, the individual surgeon, and surgeon-to-patient gender congruence.</p><p><strong>Methods: </strong>We drew on our prospectively managed database to review 43,360 consecutive thyroid surgeries. In addition to a risk factor analysis, a subanalysis of perioperative systolic blood pressure values was performed in 26 patients with postoperative hemorrhage and 26 controls, on the basis of the hypothesis that a targeted pharmacologic increase in systolic blood pressure could reveal covert sources of bleeding.</p><p><strong>Results: </strong>Postoperative hemorrhage developed in 707 of 43,360 cases (1.6%). Risk factors included older age (odds ratio, 1.017), male gender (odds ratio, 1.629), Graves disease (odds ratio, 1.515), and recurrent benign thyroid disease (odds ratio, 1.693). The individual surgeon significantly influenced the rate of postoperative hemorrhage (odds ratio, up to 2.817). Surgeon-to-patient gender (in)congruence did not affect the rate of postoperative hemorrhage. The subanalysis of perioperative blood pressure revealed mostly arterial bleeding sources (17/26 [65.4%]) and significantly lower intraoperative yet greater postoperative systolic blood pressure values (100 mm Hg vs median 120 mm Hg; P = .009; and 150 mm Hg vs 130 mm Hg; P = .005; respectively) in patients who later developed postoperative hemorrhage.</p><p><strong>Conclusion: </strong>Although our data suggest that increasing intraoperative systolic blood pressure before wound closure may help to detect covert bleeding sources and therefore prevent postoperative hemorrhage, future studies are necessary to substantiate this finding. We recommend close collaboration with anesthesiologists as well as counteracting postoperative blood pressure increases. The individual surgeon was a major factor influencing the rate of postoperative hemorrhage. However, there were no differences between female and male surgeons operating on female or male patients.</p>","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":"108910"},"PeriodicalIF":3.2,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142644720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 1(with editorial board) 封面 1(带编辑委员会)
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/S0039-6060(24)00867-5
{"title":"Cover 1(with editorial board)","authors":"","doi":"10.1016/S0039-6060(24)00867-5","DOIUrl":"10.1016/S0039-6060(24)00867-5","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Page OFC"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142663614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What I Learned as an Editor-in-Chief 作为主编我学到了什么?
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/j.surg.2024.10.004
Kevin E. Behrns MD (Editor-In-Chief, Surgery)
{"title":"What I Learned as an Editor-in-Chief","authors":"Kevin E. Behrns MD (Editor-In-Chief, Surgery)","doi":"10.1016/j.surg.2024.10.004","DOIUrl":"10.1016/j.surg.2024.10.004","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Page 1557"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142627299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reviewer Acknowledgement 审稿人致谢
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/S0039-6060(24)00866-3
{"title":"Reviewer Acknowledgement","authors":"","doi":"10.1016/S0039-6060(24)00866-3","DOIUrl":"10.1016/S0039-6060(24)00866-3","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Pages 1786-1801"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142663355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for readers 读者须知
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/S0039-6060(24)00869-9
{"title":"Information for readers","authors":"","doi":"10.1016/S0039-6060(24)00869-9","DOIUrl":"10.1016/S0039-6060(24)00869-9","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Page A1"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142663616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for authors 作者须知
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/S0039-6060(24)00871-7
{"title":"Information for authors","authors":"","doi":"10.1016/S0039-6060(24)00871-7","DOIUrl":"10.1016/S0039-6060(24)00871-7","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Pages A7-A12"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142663617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Tribute to Dr Kevin E. Behrns, Editor-in-Chief of SURGERY 向《外科手术学》主编 Kevin E. Behrns 博士致敬。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-12 DOI: 10.1016/j.surg.2024.08.041
Tyler J. Loftus MD, PhD
{"title":"A Tribute to Dr Kevin E. Behrns, Editor-in-Chief of SURGERY","authors":"Tyler J. Loftus MD, PhD","doi":"10.1016/j.surg.2024.08.041","DOIUrl":"10.1016/j.surg.2024.08.041","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":"176 6","pages":"Pages 1558-1559"},"PeriodicalIF":3.2,"publicationDate":"2024-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142626977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discussion. 讨论。
IF 3.2 2区 医学 Q1 SURGERY Pub Date : 2024-11-11 DOI: 10.1016/j.surg.2024.07.089
{"title":"Discussion.","authors":"","doi":"10.1016/j.surg.2024.07.089","DOIUrl":"https://doi.org/10.1016/j.surg.2024.07.089","url":null,"abstract":"","PeriodicalId":22152,"journal":{"name":"Surgery","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142628748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1